Ticker HubNasdaq

CODX

Co-Diagnostics, Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUSLatest afterhours mover

Latest price

$0.3151-1.22%

As of Nov 10, 2026, 7:05 PM EST · Market data by Massive

Market cap

$2.8M

Volume

74.7M

Previous close

$0.3190

Day range

$0.2635 – $0.3347

Listed

Jul 12, 2017

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $0.3670Latest interval $0.3199

Newsroom

Latest CODX coverage

Nov 10, 2026

Pre-Market Movers: PEPG, SMX, MI Lead the Small-Cap Scan

PEPG led a group of 10 active small-cap stocks flagged for editorial review.

PEPGSMXMIMNDO

Recent catalyst headlines

Co-Diagnostics Reports Third Quarter 2026 Financial Results

Nov 10, 2026

Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast

Nov 5, 2026

Co-Diagnostics to Participate in Three Global Tuberculosis Events in November as CoSara Advances Toward Anticipated India Launch

Nov 5, 2026

Company overview

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 115
Headquarters: SALT LAKE CITY, UT
CIK: 0001692415

Company website View advanced chart

SEC filings

10-Q

8-K

S-3

DEF 14A

PRE 14A

8-K/A

8-K

Browse EDGAR

Profile at a glance

Jul 12, 2017

Listed

115

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.